Saturday, 27 April 2024
Cellectar Biosciences Inc.
02:07 | 9/2/18
GlobeNewswire
MADISON, Wis., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces ...
more»
02:30 | 23/1/18
GlobeNewswire
MADISON, Wis., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces ...
more»
Cellectar Biosciences has begun shutting down manufacturing operations at its headquarters and its plan going forward will be to have one of the company's existing partners handle finished product manufacturing, Cellectar CEO Jim Caruso said Monday ...
more»
01:56 | 5/1/18
GlobeNewswire
MADISON, Wis., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces ...
more»
02:41 | 15/12/17
StreetInsider.com
Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announces that the company has filed an Investigational New ...
more»
02:30 | 21/11/17
GlobeNewswire
November 20, 2017 08:30 ET | Source: Cellectar Biosciences, Inc. Madison, Wis., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq:CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and ...
more»
08:07 | 11/11/17
Seeking Alpha
Good day, ladies and gentlemen and welcome to the Cellectar Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
more»
10:00 | 10/11/17
GlobeNewswire
MADISON, Wis., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company (the “company”), today reported financial results and corporate performance for the third quarter ...
more»
01:32 | 3/11/17
GlobeNewswire
MADISON, Wis., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), an oncology-focused, clinical stage biotechnology company, today announces that management will host a teleconference and live webcast ...
more»
04:56 | 2/11/17
TrueBlueTribune
Cellectar Biosciences logo Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |